{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 4,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 0
      },
      "3": {
        "core": 1,
        "branch": 1
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 → G)",
        "prover9_expression": "(researched(substance_x) -> beneficial_to_patients(substance_x))",
        "natural": "Provided that substance X has been researched, then it follows that it is beneficial to patients."
      },
      {
        "id": "Rule2",
        "formal": "(A12 → ¬A11)",
        "prover9_expression": "(withdrawn_from_market(substance_x) -> -requires_modification(device_w))",
        "natural": "Whenever substance X is withdrawn from market, then device W does not require modification."
      },
      {
        "id": "Rule3",
        "formal": "(A13 → G)",
        "prover9_expression": "(passes_safety_test(substance_x) -> beneficial_to_patients(substance_x))",
        "natural": "If substance X passes safety test, then it is beneficial to patients."
      },
      {
        "id": "Rule4",
        "formal": "(A14 → G)",
        "prover9_expression": "(shows_promise(substance_x) -> beneficial_to_patients(substance_x))",
        "natural": "Under the condition that substance X shows promise, then it is beneficial to patients."
      },
      {
        "id": "Rule5",
        "formal": "(A15 ∨ A16)",
        "prover9_expression": "(completes_phase_ii(substance_x) | enters_phase_iii(substance_x))",
        "natural": "Either substance X completes phase II or it enters phase III."
      },
      {
        "id": "Rule6",
        "formal": "(A16 → A14)",
        "prover9_expression": "(enters_phase_iii(substance_x) -> shows_promise(substance_x))",
        "natural": "If substance X enters phase III, then it shows promise."
      },
      {
        "id": "Rule7",
        "formal": "(A18 → A23)",
        "prover9_expression": "(generates_revenue(substance_x) -> achieves_commercial_success(substance_x))",
        "natural": "Whenever substance X generates revenue, then it achieves commercial success."
      },
      {
        "id": "Rule8",
        "formal": "(A20 → A19)",
        "prover9_expression": "(demonstrates_cost_effectiveness(substance_x) -> attracts_investment(project_p))",
        "natural": "Provided that substance X demonstrates cost effectiveness, then project P attracts investment."
      },
      {
        "id": "Rule9",
        "formal": "(A20 ∨ A21)",
        "prover9_expression": "(demonstrates_cost_effectiveness(substance_x) | faces_regulatory_hurdles(substance_x))",
        "natural": "Substance X demonstrates cost effectiveness or it faces regulatory hurdles."
      },
      {
        "id": "Rule10",
        "formal": "(A24 → ¬A23)",
        "prover9_expression": "(improves_patient_outcomes(substance_x) -> -achieves_commercial_success(substance_x))",
        "natural": "Under the condition that substance X improves patient outcomes, then it does not achieve commercial success."
      },
      {
        "id": "Rule11",
        "formal": "(A25 → A24)",
        "prover9_expression": "(reduces_symptoms(disease_d) -> improves_patient_outcomes(substance_x))",
        "natural": "Provided that it reduces symptoms of disease D, then substance X improves patient outcomes."
      },
      {
        "id": "Rule12",
        "formal": "(A25 ∨ A26)",
        "prover9_expression": "(reduces_symptoms(disease_d) | prevents_progression(disease_d))",
        "natural": "It reduces symptoms of disease D or it prevents progression of disease D."
      },
      {
        "id": "Rule13",
        "formal": "(A27 → A28)",
        "prover9_expression": "(creates_confusion(study_results) -> provides_clarity(study_results))",
        "natural": "If study results create confusion, then they provide clarity."
      },
      {
        "id": "Rule14",
        "formal": "(A29 → (A27 → ¬A28))",
        "prover9_expression": "(contains_contradictions(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
        "natural": "Under the condition that study results contain contradictions, then if they create confusion, they do not provide clarity."
      },
      {
        "id": "Rule15",
        "formal": "(A29 ∨ A30)",
        "prover9_expression": "(contains_contradictions(study_results) | has_methodological_flaws(study_results))",
        "natural": "Study results contain contradictions or they have methodological flaws."
      },
      {
        "id": "Rule16",
        "formal": "(A31 → (A27 → ¬A28))",
        "prover9_expression": "(needs_replication(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
        "natural": "Provided that study results need replication, then if they create confusion, they do not provide clarity."
      },
      {
        "id": "Rule17",
        "formal": "(A4 → A5)",
        "prover9_expression": "(approved_by(fda_agency) -> causes_side_effects(substance_x))",
        "natural": "If it was approved by the FDA agency, then substance X causes side effects."
      },
      {
        "id": "Rule18",
        "formal": "(A4 ∨ (¬(¬A1 → A2) → A3))",
        "prover9_expression": "(approved_by(fda_agency) | (-(-researched(substance_x) -> published_on(platform_y)) -> tested_on(animal_model_z)))",
        "natural": "It was approved by the FDA agency or if it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z."
      },
      {
        "id": "Rule19",
        "formal": "(A7 → (¬(A4 → ¬A5) → A6))",
        "prover9_expression": "(treats(disease_d) -> (-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> requires_monitoring(device_w)))",
        "natural": "Provided that it treats disease D, then if it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring."
      },
      {
        "id": "Rule20",
        "formal": "(A9 ∨ (¬G → ¬A8))",
        "prover9_expression": "(shows_efficacy(substance_x) | (-beneficial_to_patients(substance_x) -> -exhibits_toxicity(substance_x)))",
        "natural": "Substance X shows efficacy or if it is not the case that it is beneficial to patients then it does not exhibit toxicity."
      },
      {
        "id": "Rule21",
        "formal": "(¬(A10 ∨ ¬A9) → A11)",
        "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> requires_modification(device_w))",
        "natural": "If it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W requires modification."
      },
      {
        "id": "Rule22",
        "formal": "(¬(A10 ∨ ¬A9) → A12)",
        "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> withdrawn_from_market(substance_x))",
        "natural": "Provided that it is not the case that either substance X fails clinical trial or it does not show efficacy, then it is withdrawn from market."
      },
      {
        "id": "Rule23",
        "formal": "(¬(A15 → A13) → A17)",
        "prover9_expression": "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> receives_funding(project_p))",
        "natural": "If it is not the case that if substance X completes phase II then it passes safety test, then project P receives funding."
      },
      {
        "id": "Rule24",
        "formal": "(¬(A21 → ¬A18) → A22)",
        "prover9_expression": "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> undergoes_review(device_w))",
        "natural": "Whenever it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W undergoes review."
      },
      {
        "id": "Rule25",
        "formal": "(¬(A21 → ¬A18) → ¬A22)",
        "prover9_expression": "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> -undergoes_review(device_w))",
        "natural": "If it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W does not undergo review."
      },
      {
        "id": "Rule26",
        "formal": "(¬(A26 → A24) → A27)",
        "prover9_expression": "(-(prevents_progression(disease_d) -> improves_patient_outcomes(substance_x)) -> creates_confusion(study_results))",
        "natural": "Provided that it is not the case that if it prevents progression of disease D then substance X improves patient outcomes, then study results create confusion."
      },
      {
        "id": "Rule27",
        "formal": "(¬(A30 → A31) → A32)",
        "prover9_expression": "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> requires_peer_review(study_results))",
        "natural": "Under the condition that it is not the case that if study results have methodological flaws then they need replication, then they require peer review."
      },
      {
        "id": "Rule28",
        "formal": "(¬(A30 → A31) → ¬A32)",
        "prover9_expression": "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> -requires_peer_review(study_results))",
        "natural": "If it is not the case that if study results have methodological flaws then they need replication, then they do not require peer review."
      },
      {
        "id": "Rule29",
        "formal": "(¬(A4 → ¬A5) → ¬A6)",
        "prover9_expression": "(-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> -requires_monitoring(device_w))",
        "natural": "Whenever it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W does not require monitoring."
      },
      {
        "id": "Rule30",
        "formal": "(¬(¬(A15 → A13) → ¬A17) → A18)",
        "prover9_expression": "(-(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p)) -> generates_revenue(substance_x))",
        "natural": "If it is not the case that if it is not the case that if substance X completes phase II then it passes safety test then project P does not receive funding, then substance X generates revenue."
      },
      {
        "id": "Rule31",
        "formal": "(¬(¬A1 → A2) → ¬A3)",
        "prover9_expression": "(-(-researched(substance_x) -> published_on(platform_y)) -> -tested_on(animal_model_z))",
        "natural": "Under the condition that it is not the case that if substance X was not researched then it was published on platform Y, then it was not tested on animal model Z."
      },
      {
        "id": "Rule32",
        "formal": "(¬G → A8)",
        "prover9_expression": "(-beneficial_to_patients(substance_x) -> exhibits_toxicity(substance_x))",
        "natural": "Provided that it is not the case that substance X is beneficial to patients, then it exhibits toxicity."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A7",
        "prover9_expression": "treats(disease_d)",
        "natural": "It treats disease D."
      },
      {
        "id": "Fact2",
        "formal": "¬A10",
        "prover9_expression": "-fails_clinical_trial(substance_x)",
        "natural": "It is not the case that substance X fails clinical trial."
      },
      {
        "id": "Fact3",
        "formal": "¬A19",
        "prover9_expression": "-attracts_investment(project_p)",
        "natural": "It is not the case that project P attracts investment."
      },
      {
        "id": "Fact4",
        "formal": "¬A2",
        "prover9_expression": "-published_on(platform_y)",
        "natural": "It is not the case that the research was published on platform Y."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "beneficial_to_patients(substance_x)",
    "natural": "Substance X is beneficial to patients."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A7 -> (-(A4 -> -A5) -> A6))",
            "A7"
          ],
          "conclusion": "(-(A4 -> -A5) -> A6)",
          "natural": "Provided that it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A4 -> -A5) -> A6)",
            "(-(A4 -> -A5) -> -A6)"
          ],
          "conclusion": "(A4 -> -A5)",
          "natural": "Under the condition that it was approved by the FDA agency, then substance X does not cause side effects."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(A4 -> A5)",
            "(A4 -> -A5)"
          ],
          "conclusion": "-A4",
          "natural": "It is not the case that it was approved by the FDA agency."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A4 | (-(-A1 -> A2) -> A3))",
            "-A4"
          ],
          "conclusion": "(-(-A1 -> A2) -> A3)",
          "natural": "Provided that it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-A1 -> A2) -> A3)",
            "(-(-A1 -> A2) -> -A3)"
          ],
          "conclusion": "(-A1 -> A2)",
          "natural": "If substance X was not researched, then it was published on platform Y."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            "(-A1 -> A2)",
            "-A2"
          ],
          "conclusion": "A1",
          "natural": "Substance X has been researched."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            "(A1 -> G)",
            "A1"
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A10 | -A9) -> A12)",
            "(A12 -> -A11)"
          ],
          "conclusion": "(-(A10 | -A9) -> -A11)",
          "natural": "Under the condition that it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W does not require modification."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A10 | -A9) -> A11)",
            "(-(A10 | -A9) -> -A11)"
          ],
          "conclusion": "(A10 | -A9)",
          "natural": "Either substance X fails clinical trial or it is not the case that it shows efficacy."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A10 | -A9)",
            "-A10"
          ],
          "conclusion": "-A9",
          "natural": "It is not the case that substance X shows efficacy."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A9 | (-G -> -A8))",
            "-A9"
          ],
          "conclusion": "(-G -> -A8)",
          "natural": "If it is not the case that substance X is beneficial to patients, then it does not exhibit toxicity."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A8)",
            "(-G -> -A8)"
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A21 -> -A18) -> A22)",
            "(-(A21 -> -A18) -> -A22)"
          ],
          "conclusion": "(A21 -> -A18)",
          "natural": "If substance X faces regulatory hurdles, then it does not generate revenue."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A20 -> A19)",
            "(A21 -> -A18)",
            "(A20 | A21)"
          ],
          "conclusion": "(A19 | -A18)",
          "natural": "Project P attracts investment or it is not the case that substance X generates revenue."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | -A18)",
            "-A19"
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that substance X generates revenue."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A15 -> A13) -> -A17) -> A18)",
            "-A18"
          ],
          "conclusion": "(-(A15 -> A13) -> -A17)",
          "natural": "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A15 -> A13) -> A17)",
            "(-(A15 -> A13) -> -A17)"
          ],
          "conclusion": "(A15 -> A13)",
          "natural": "Provided that substance X completes phase II, then it passes safety test."
        },
        {
          "step_number": 6,
          "rule_applied": "CD",
          "premises_used": [
            "(A15 -> A13)",
            "(A16 -> A14)",
            "(A15 | A16)"
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Substance X passes safety test or it shows promise."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            "(A13 | A14)",
            "(A13 -> G)",
            "(A14 -> G)"
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A30 -> A31) -> A32)",
            "(-(A30 -> A31) -> -A32)"
          ],
          "conclusion": "(A30 -> A31)",
          "natural": "Whenever study results have methodological flaws, then they need replication."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A30 -> A31)",
            "(A31 -> (A27 -> -A28))"
          ],
          "conclusion": "(A30 -> (A27 -> -A28))",
          "natural": "If study results have methodological flaws, then provided that they create confusion, they do not provide clarity."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            "(A29 | A30)",
            "(A29 -> (A27 -> -A28))",
            "(A30 -> (A27 -> -A28))"
          ],
          "conclusion": "(A27 -> -A28)",
          "natural": "Provided that study results create confusion, then they do not provide clarity."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(A27 -> A28)",
            "(A27 -> -A28)"
          ],
          "conclusion": "-A27",
          "natural": "It is not the case that study results create confusion."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A26 -> A24) -> A27)",
            "-A27"
          ],
          "conclusion": "(A26 -> A24)",
          "natural": "Whenever it prevents progression of disease D, then substance X improves patient outcomes."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A25 | A26)",
            "(A25 -> A24)",
            "(A26 -> A24)"
          ],
          "conclusion": "A24",
          "natural": "Substance X improves patient outcomes."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            "(A24 -> -A23)",
            "A24"
          ],
          "conclusion": "-A23",
          "natural": "It is not the case that substance X achieves commercial success."
        },
        {
          "step_number": 8,
          "rule_applied": "MT",
          "premises_used": [
            "(A18 -> A23)",
            "-A23"
          ],
          "conclusion": "-A18",
          "natural": "It is not the case that substance X generates revenue."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A15 -> A13) -> -A17) -> A18)",
            "-A18"
          ],
          "conclusion": "(-(A15 -> A13) -> -A17)",
          "natural": "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding."
        },
        {
          "step_number": 10,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A15 -> A13) -> A17)",
            "(-(A15 -> A13) -> -A17)"
          ],
          "conclusion": "(A15 -> A13)",
          "natural": "Provided that substance X completes phase II, then it passes safety test."
        },
        {
          "step_number": 11,
          "rule_applied": "CD",
          "premises_used": [
            "(A15 -> A13)",
            "(A16 -> A14)",
            "(A15 | A16)"
          ],
          "conclusion": "(A13 | A14)",
          "natural": "Substance X passes safety test or it shows promise."
        },
        {
          "step_number": 12,
          "rule_applied": "DE",
          "premises_used": [
            "(A13 | A14)",
            "(A13 -> G)",
            "(A14 -> G)"
          ],
          "conclusion": "G",
          "natural": "Substance X is beneficial to patients."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Biomedical Research",
    "atomic_facts": {
      "A1": "researched(substance_x)",
      "A2": "published_on(platform_y)",
      "A3": "tested_on(animal_model_z)",
      "A4": "approved_by(fda_agency)",
      "A5": "causes_side_effects(substance_x)",
      "A6": "requires_monitoring(device_w)",
      "A7": "treats(disease_d)",
      "A8": "exhibits_toxicity(substance_x)",
      "A9": "shows_efficacy(substance_x)",
      "A10": "fails_clinical_trial(substance_x)",
      "A11": "requires_modification(device_w)",
      "A12": "withdrawn_from_market(substance_x)",
      "A13": "passes_safety_test(substance_x)",
      "A14": "shows_promise(substance_x)",
      "A15": "completes_phase_ii(substance_x)",
      "A16": "enters_phase_iii(substance_x)",
      "A17": "receives_funding(project_p)",
      "A18": "generates_revenue(substance_x)",
      "A19": "attracts_investment(project_p)",
      "A20": "demonstrates_cost_effectiveness(substance_x)",
      "A21": "faces_regulatory_hurdles(substance_x)",
      "A22": "undergoes_review(device_w)",
      "A23": "achieves_commercial_success(substance_x)",
      "A24": "improves_patient_outcomes(substance_x)",
      "A25": "reduces_symptoms(disease_d)",
      "A26": "prevents_progression(disease_d)",
      "A27": "creates_confusion(study_results)",
      "A28": "provides_clarity(study_results)",
      "A29": "contains_contradictions(study_results)",
      "A30": "has_methodological_flaws(study_results)",
      "A31": "needs_replication(study_results)",
      "A32": "requires_peer_review(study_results)",
      "G": "beneficial_to_patients(substance_x)"
    },
    "natural_facts": {
      "A1": "Substance X has been researched.",
      "A2": "The research was published on platform Y.",
      "A3": "It was tested on animal model Z.",
      "A4": "It was approved by the FDA agency.",
      "A5": "Substance X causes side effects.",
      "A6": "Device W requires monitoring.",
      "A7": "It treats disease D.",
      "A8": "Substance X exhibits toxicity.",
      "A9": "Substance X shows efficacy.",
      "A10": "Substance X fails clinical trial.",
      "A11": "Device W requires modification.",
      "A12": "Substance X is withdrawn from market.",
      "A13": "Substance X passes safety test.",
      "A14": "Substance X shows promise.",
      "A15": "Substance X completes phase II.",
      "A16": "Substance X enters phase III.",
      "A17": "Project P receives funding.",
      "A18": "Substance X generates revenue.",
      "A19": "Project P attracts investment.",
      "A20": "Substance X demonstrates cost effectiveness.",
      "A21": "Substance X faces regulatory hurdles.",
      "A22": "Device W undergoes review.",
      "A23": "Substance X achieves commercial success.",
      "A24": "Substance X improves patient outcomes.",
      "A25": "It reduces symptoms of disease D.",
      "A26": "It prevents progression of disease D.",
      "A27": "Study results create confusion.",
      "A28": "Study results provide clarity.",
      "A29": "Study results contain contradictions.",
      "A30": "Study results have methodological flaws.",
      "A31": "Study results need replication.",
      "A32": "Study results require peer review.",
      "G": "Substance X is beneficial to patients."
    },
    "prover9_expressions": [
      "(researched(substance_x) -> beneficial_to_patients(substance_x))",
      "(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x))",
      "(withdrawn_from_market(substance_x) -> -requires_modification(device_w))",
      "(passes_safety_test(substance_x) -> beneficial_to_patients(substance_x))",
      "(passes_safety_test(substance_x) | shows_promise(substance_x))",
      "(shows_promise(substance_x) -> beneficial_to_patients(substance_x))",
      "(completes_phase_ii(substance_x) -> passes_safety_test(substance_x))",
      "(completes_phase_ii(substance_x) | enters_phase_iii(substance_x))",
      "(enters_phase_iii(substance_x) -> shows_promise(substance_x))",
      "(generates_revenue(substance_x) -> achieves_commercial_success(substance_x))",
      "(attracts_investment(project_p) | -generates_revenue(substance_x))",
      "(demonstrates_cost_effectiveness(substance_x) -> attracts_investment(project_p))",
      "(demonstrates_cost_effectiveness(substance_x) | faces_regulatory_hurdles(substance_x))",
      "(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x))",
      "(improves_patient_outcomes(substance_x) -> -achieves_commercial_success(substance_x))",
      "(reduces_symptoms(disease_d) -> improves_patient_outcomes(substance_x))",
      "(reduces_symptoms(disease_d) | prevents_progression(disease_d))",
      "(prevents_progression(disease_d) -> improves_patient_outcomes(substance_x))",
      "(creates_confusion(study_results) -> provides_clarity(study_results))",
      "(creates_confusion(study_results) -> -provides_clarity(study_results))",
      "(contains_contradictions(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
      "(contains_contradictions(study_results) | has_methodological_flaws(study_results))",
      "(has_methodological_flaws(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
      "(has_methodological_flaws(study_results) -> needs_replication(study_results))",
      "(needs_replication(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
      "(approved_by(fda_agency) -> causes_side_effects(substance_x))",
      "(approved_by(fda_agency) -> -causes_side_effects(substance_x))",
      "(approved_by(fda_agency) | (-(-researched(substance_x) -> published_on(platform_y)) -> tested_on(animal_model_z)))",
      "(treats(disease_d) -> (-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> requires_monitoring(device_w)))",
      "(shows_efficacy(substance_x) | (-beneficial_to_patients(substance_x) -> -exhibits_toxicity(substance_x)))",
      "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> requires_modification(device_w))",
      "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> withdrawn_from_market(substance_x))",
      "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> -requires_modification(device_w))",
      "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> receives_funding(project_p))",
      "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p))",
      "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> undergoes_review(device_w))",
      "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> -undergoes_review(device_w))",
      "(-(prevents_progression(disease_d) -> improves_patient_outcomes(substance_x)) -> creates_confusion(study_results))",
      "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> requires_peer_review(study_results))",
      "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> -requires_peer_review(study_results))",
      "(-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> requires_monitoring(device_w))",
      "(-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> -requires_monitoring(device_w))",
      "(-(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p)) -> generates_revenue(substance_x))",
      "(-(-researched(substance_x) -> published_on(platform_y)) -> tested_on(animal_model_z))",
      "(-(-researched(substance_x) -> published_on(platform_y)) -> -tested_on(animal_model_z))",
      "(-researched(substance_x) -> published_on(platform_y))",
      "(-beneficial_to_patients(substance_x) -> exhibits_toxicity(substance_x))",
      "(-beneficial_to_patients(substance_x) -> -exhibits_toxicity(substance_x))",
      "researched(substance_x)",
      "improves_patient_outcomes(substance_x)",
      "treats(disease_d)",
      "beneficial_to_patients(substance_x)",
      "-fails_clinical_trial(substance_x)",
      "-generates_revenue(substance_x)",
      "-attracts_investment(project_p)",
      "-published_on(platform_y)",
      "-achieves_commercial_success(substance_x)",
      "-creates_confusion(study_results)",
      "-approved_by(fda_agency)",
      "-shows_efficacy(substance_x)"
    ],
    "natural_expressions": [
      "Provided that substance X has been researched, then it follows that it is beneficial to patients.",
      "Either substance X fails clinical trial or it is not the case that it shows efficacy.",
      "Whenever substance X is withdrawn from market, then device W does not require modification.",
      "If substance X passes safety test, then it is beneficial to patients.",
      "Substance X passes safety test or it shows promise.",
      "Under the condition that substance X shows promise, then it is beneficial to patients.",
      "Provided that substance X completes phase II, then it passes safety test.",
      "Either substance X completes phase II or it enters phase III.",
      "If substance X enters phase III, then it shows promise.",
      "Whenever substance X generates revenue, then it achieves commercial success.",
      "Project P attracts investment or it is not the case that substance X generates revenue.",
      "Provided that substance X demonstrates cost effectiveness, then project P attracts investment.",
      "Substance X demonstrates cost effectiveness or it faces regulatory hurdles.",
      "If substance X faces regulatory hurdles, then it does not generate revenue.",
      "Under the condition that substance X improves patient outcomes, then it does not achieve commercial success.",
      "Provided that it reduces symptoms of disease D, then substance X improves patient outcomes.",
      "It reduces symptoms of disease D or it prevents progression of disease D.",
      "Whenever it prevents progression of disease D, then substance X improves patient outcomes.",
      "If study results create confusion, then they provide clarity.",
      "Provided that study results create confusion, then they do not provide clarity.",
      "Under the condition that study results contain contradictions, then if they create confusion, they do not provide clarity.",
      "Study results contain contradictions or they have methodological flaws.",
      "If study results have methodological flaws, then provided that they create confusion, they do not provide clarity.",
      "Whenever study results have methodological flaws, then they need replication.",
      "Provided that study results need replication, then if they create confusion, they do not provide clarity.",
      "If it was approved by the FDA agency, then substance X causes side effects.",
      "Under the condition that it was approved by the FDA agency, then substance X does not cause side effects.",
      "It was approved by the FDA agency or if it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z.",
      "Provided that it treats disease D, then if it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring.",
      "Substance X shows efficacy or if it is not the case that it is beneficial to patients then it does not exhibit toxicity.",
      "If it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W requires modification.",
      "Provided that it is not the case that either substance X fails clinical trial or it does not show efficacy, then it is withdrawn from market.",
      "Under the condition that it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W does not require modification.",
      "If it is not the case that if substance X completes phase II then it passes safety test, then project P receives funding.",
      "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding.",
      "Whenever it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W undergoes review.",
      "If it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W does not undergo review.",
      "Provided that it is not the case that if it prevents progression of disease D then substance X improves patient outcomes, then study results create confusion.",
      "Under the condition that it is not the case that if study results have methodological flaws then they need replication, then they require peer review.",
      "If it is not the case that if study results have methodological flaws then they need replication, then they do not require peer review.",
      "Provided that it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring.",
      "Whenever it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W does not require monitoring.",
      "If it is not the case that if it is not the case that if substance X completes phase II then it passes safety test then project P does not receive funding, then substance X generates revenue.",
      "Provided that it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z.",
      "Under the condition that it is not the case that if substance X was not researched then it was published on platform Y, then it was not tested on animal model Z.",
      "If substance X was not researched, then it was published on platform Y.",
      "Provided that it is not the case that substance X is beneficial to patients, then it exhibits toxicity.",
      "If it is not the case that substance X is beneficial to patients, then it does not exhibit toxicity.",
      "Substance X has been researched.",
      "Substance X improves patient outcomes.",
      "It treats disease D.",
      "Substance X is beneficial to patients.",
      "It is not the case that substance X fails clinical trial.",
      "It is not the case that substance X generates revenue.",
      "It is not the case that project P attracts investment.",
      "It is not the case that the research was published on platform Y.",
      "It is not the case that substance X achieves commercial success.",
      "It is not the case that study results create confusion.",
      "It is not the case that it was approved by the FDA agency.",
      "It is not the case that substance X shows efficacy."
    ],
    "node_mappings": {
      "(A1 → G)": {
        "formal": "(A1 → G)",
        "prover9": "(A1 -> G)",
        "prover9_expression": "(researched(substance_x) -> beneficial_to_patients(substance_x))",
        "natural": "Provided that substance X has been researched, then it follows that it is beneficial to patients."
      },
      "(A10 ∨ ¬A9)": {
        "formal": "(A10 ∨ ¬A9)",
        "prover9": "(A10 | -A9)",
        "prover9_expression": "(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x))",
        "natural": "Either substance X fails clinical trial or it is not the case that it shows efficacy."
      },
      "(A12 → ¬A11)": {
        "formal": "(A12 → ¬A11)",
        "prover9": "(A12 -> -A11)",
        "prover9_expression": "(withdrawn_from_market(substance_x) -> -requires_modification(device_w))",
        "natural": "Whenever substance X is withdrawn from market, then device W does not require modification."
      },
      "(A13 → G)": {
        "formal": "(A13 → G)",
        "prover9": "(A13 -> G)",
        "prover9_expression": "(passes_safety_test(substance_x) -> beneficial_to_patients(substance_x))",
        "natural": "If substance X passes safety test, then it is beneficial to patients."
      },
      "(A13 ∨ A14)": {
        "formal": "(A13 ∨ A14)",
        "prover9": "(A13 | A14)",
        "prover9_expression": "(passes_safety_test(substance_x) | shows_promise(substance_x))",
        "natural": "Substance X passes safety test or it shows promise."
      },
      "(A14 → G)": {
        "formal": "(A14 → G)",
        "prover9": "(A14 -> G)",
        "prover9_expression": "(shows_promise(substance_x) -> beneficial_to_patients(substance_x))",
        "natural": "Under the condition that substance X shows promise, then it is beneficial to patients."
      },
      "(A15 → A13)": {
        "formal": "(A15 → A13)",
        "prover9": "(A15 -> A13)",
        "prover9_expression": "(completes_phase_ii(substance_x) -> passes_safety_test(substance_x))",
        "natural": "Provided that substance X completes phase II, then it passes safety test."
      },
      "(A15 ∨ A16)": {
        "formal": "(A15 ∨ A16)",
        "prover9": "(A15 | A16)",
        "prover9_expression": "(completes_phase_ii(substance_x) | enters_phase_iii(substance_x))",
        "natural": "Either substance X completes phase II or it enters phase III."
      },
      "(A16 → A14)": {
        "formal": "(A16 → A14)",
        "prover9": "(A16 -> A14)",
        "prover9_expression": "(enters_phase_iii(substance_x) -> shows_promise(substance_x))",
        "natural": "If substance X enters phase III, then it shows promise."
      },
      "(A18 → A23)": {
        "formal": "(A18 → A23)",
        "prover9": "(A18 -> A23)",
        "prover9_expression": "(generates_revenue(substance_x) -> achieves_commercial_success(substance_x))",
        "natural": "Whenever substance X generates revenue, then it achieves commercial success."
      },
      "(A19 ∨ ¬A18)": {
        "formal": "(A19 ∨ ¬A18)",
        "prover9": "(A19 | -A18)",
        "prover9_expression": "(attracts_investment(project_p) | -generates_revenue(substance_x))",
        "natural": "Project P attracts investment or it is not the case that substance X generates revenue."
      },
      "(A20 → A19)": {
        "formal": "(A20 → A19)",
        "prover9": "(A20 -> A19)",
        "prover9_expression": "(demonstrates_cost_effectiveness(substance_x) -> attracts_investment(project_p))",
        "natural": "Provided that substance X demonstrates cost effectiveness, then project P attracts investment."
      },
      "(A20 ∨ A21)": {
        "formal": "(A20 ∨ A21)",
        "prover9": "(A20 | A21)",
        "prover9_expression": "(demonstrates_cost_effectiveness(substance_x) | faces_regulatory_hurdles(substance_x))",
        "natural": "Substance X demonstrates cost effectiveness or it faces regulatory hurdles."
      },
      "(A21 → ¬A18)": {
        "formal": "(A21 → ¬A18)",
        "prover9": "(A21 -> -A18)",
        "prover9_expression": "(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x))",
        "natural": "If substance X faces regulatory hurdles, then it does not generate revenue."
      },
      "(A24 → ¬A23)": {
        "formal": "(A24 → ¬A23)",
        "prover9": "(A24 -> -A23)",
        "prover9_expression": "(improves_patient_outcomes(substance_x) -> -achieves_commercial_success(substance_x))",
        "natural": "Under the condition that substance X improves patient outcomes, then it does not achieve commercial success."
      },
      "(A25 → A24)": {
        "formal": "(A25 → A24)",
        "prover9": "(A25 -> A24)",
        "prover9_expression": "(reduces_symptoms(disease_d) -> improves_patient_outcomes(substance_x))",
        "natural": "Provided that it reduces symptoms of disease D, then substance X improves patient outcomes."
      },
      "(A25 ∨ A26)": {
        "formal": "(A25 ∨ A26)",
        "prover9": "(A25 | A26)",
        "prover9_expression": "(reduces_symptoms(disease_d) | prevents_progression(disease_d))",
        "natural": "It reduces symptoms of disease D or it prevents progression of disease D."
      },
      "(A26 → A24)": {
        "formal": "(A26 → A24)",
        "prover9": "(A26 -> A24)",
        "prover9_expression": "(prevents_progression(disease_d) -> improves_patient_outcomes(substance_x))",
        "natural": "Whenever it prevents progression of disease D, then substance X improves patient outcomes."
      },
      "(A27 → A28)": {
        "formal": "(A27 → A28)",
        "prover9": "(A27 -> A28)",
        "prover9_expression": "(creates_confusion(study_results) -> provides_clarity(study_results))",
        "natural": "If study results create confusion, then they provide clarity."
      },
      "(A27 → ¬A28)": {
        "formal": "(A27 → ¬A28)",
        "prover9": "(A27 -> -A28)",
        "prover9_expression": "(creates_confusion(study_results) -> -provides_clarity(study_results))",
        "natural": "Provided that study results create confusion, then they do not provide clarity."
      },
      "(A29 → (A27 → ¬A28))": {
        "formal": "(A29 → (A27 → ¬A28))",
        "prover9": "(A29 -> (A27 -> -A28))",
        "prover9_expression": "(contains_contradictions(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
        "natural": "Under the condition that study results contain contradictions, then if they create confusion, they do not provide clarity."
      },
      "(A29 ∨ A30)": {
        "formal": "(A29 ∨ A30)",
        "prover9": "(A29 | A30)",
        "prover9_expression": "(contains_contradictions(study_results) | has_methodological_flaws(study_results))",
        "natural": "Study results contain contradictions or they have methodological flaws."
      },
      "(A30 → (A27 → ¬A28))": {
        "formal": "(A30 → (A27 → ¬A28))",
        "prover9": "(A30 -> (A27 -> -A28))",
        "prover9_expression": "(has_methodological_flaws(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
        "natural": "If study results have methodological flaws, then provided that they create confusion, they do not provide clarity."
      },
      "(A30 → A31)": {
        "formal": "(A30 → A31)",
        "prover9": "(A30 -> A31)",
        "prover9_expression": "(has_methodological_flaws(study_results) -> needs_replication(study_results))",
        "natural": "Whenever study results have methodological flaws, then they need replication."
      },
      "(A31 → (A27 → ¬A28))": {
        "formal": "(A31 → (A27 → ¬A28))",
        "prover9": "(A31 -> (A27 -> -A28))",
        "prover9_expression": "(needs_replication(study_results) -> (creates_confusion(study_results) -> -provides_clarity(study_results)))",
        "natural": "Provided that study results need replication, then if they create confusion, they do not provide clarity."
      },
      "(A4 → A5)": {
        "formal": "(A4 → A5)",
        "prover9": "(A4 -> A5)",
        "prover9_expression": "(approved_by(fda_agency) -> causes_side_effects(substance_x))",
        "natural": "If it was approved by the FDA agency, then substance X causes side effects."
      },
      "(A4 → ¬A5)": {
        "formal": "(A4 → ¬A5)",
        "prover9": "(A4 -> -A5)",
        "prover9_expression": "(approved_by(fda_agency) -> -causes_side_effects(substance_x))",
        "natural": "Under the condition that it was approved by the FDA agency, then substance X does not cause side effects."
      },
      "(A4 ∨ (¬(¬A1 → A2) → A3))": {
        "formal": "(A4 ∨ (¬(¬A1 → A2) → A3))",
        "prover9": "(A4 | (-(-A1 -> A2) -> A3))",
        "prover9_expression": "(approved_by(fda_agency) | (-(-researched(substance_x) -> published_on(platform_y)) -> tested_on(animal_model_z)))",
        "natural": "It was approved by the FDA agency or if it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z."
      },
      "(A7 → (¬(A4 → ¬A5) → A6))": {
        "formal": "(A7 → (¬(A4 → ¬A5) → A6))",
        "prover9": "(A7 -> (-(A4 -> -A5) -> A6))",
        "prover9_expression": "(treats(disease_d) -> (-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> requires_monitoring(device_w)))",
        "natural": "Provided that it treats disease D, then if it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring."
      },
      "(A9 ∨ (¬G → ¬A8))": {
        "formal": "(A9 ∨ (¬G → ¬A8))",
        "prover9": "(A9 | (-G -> -A8))",
        "prover9_expression": "(shows_efficacy(substance_x) | (-beneficial_to_patients(substance_x) -> -exhibits_toxicity(substance_x)))",
        "natural": "Substance X shows efficacy or if it is not the case that it is beneficial to patients then it does not exhibit toxicity."
      },
      "(¬(A10 ∨ ¬A9) → A11)": {
        "formal": "(¬(A10 ∨ ¬A9) → A11)",
        "prover9": "(-(A10 | -A9) -> A11)",
        "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> requires_modification(device_w))",
        "natural": "If it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W requires modification."
      },
      "(¬(A10 ∨ ¬A9) → A12)": {
        "formal": "(¬(A10 ∨ ¬A9) → A12)",
        "prover9": "(-(A10 | -A9) -> A12)",
        "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> withdrawn_from_market(substance_x))",
        "natural": "Provided that it is not the case that either substance X fails clinical trial or it does not show efficacy, then it is withdrawn from market."
      },
      "(¬(A10 ∨ ¬A9) → ¬A11)": {
        "formal": "(¬(A10 ∨ ¬A9) → ¬A11)",
        "prover9": "(-(A10 | -A9) -> -A11)",
        "prover9_expression": "(-(fails_clinical_trial(substance_x) | -shows_efficacy(substance_x)) -> -requires_modification(device_w))",
        "natural": "Under the condition that it is not the case that either substance X fails clinical trial or it does not show efficacy, then device W does not require modification."
      },
      "(¬(A15 → A13) → A17)": {
        "formal": "(¬(A15 → A13) → A17)",
        "prover9": "(-(A15 -> A13) -> A17)",
        "prover9_expression": "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> receives_funding(project_p))",
        "natural": "If it is not the case that if substance X completes phase II then it passes safety test, then project P receives funding."
      },
      "(¬(A15 → A13) → ¬A17)": {
        "formal": "(¬(A15 → A13) → ¬A17)",
        "prover9": "(-(A15 -> A13) -> -A17)",
        "prover9_expression": "(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p))",
        "natural": "Provided that it is not the case that if substance X completes phase II then it passes safety test, then project P does not receive funding."
      },
      "(¬(A21 → ¬A18) → A22)": {
        "formal": "(¬(A21 → ¬A18) → A22)",
        "prover9": "(-(A21 -> -A18) -> A22)",
        "prover9_expression": "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> undergoes_review(device_w))",
        "natural": "Whenever it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W undergoes review."
      },
      "(¬(A21 → ¬A18) → ¬A22)": {
        "formal": "(¬(A21 → ¬A18) → ¬A22)",
        "prover9": "(-(A21 -> -A18) -> -A22)",
        "prover9_expression": "(-(faces_regulatory_hurdles(substance_x) -> -generates_revenue(substance_x)) -> -undergoes_review(device_w))",
        "natural": "If it is not the case that if substance X faces regulatory hurdles then it does not generate revenue, then device W does not undergo review."
      },
      "(¬(A26 → A24) → A27)": {
        "formal": "(¬(A26 → A24) → A27)",
        "prover9": "(-(A26 -> A24) -> A27)",
        "prover9_expression": "(-(prevents_progression(disease_d) -> improves_patient_outcomes(substance_x)) -> creates_confusion(study_results))",
        "natural": "Provided that it is not the case that if it prevents progression of disease D then substance X improves patient outcomes, then study results create confusion."
      },
      "(¬(A30 → A31) → A32)": {
        "formal": "(¬(A30 → A31) → A32)",
        "prover9": "(-(A30 -> A31) -> A32)",
        "prover9_expression": "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> requires_peer_review(study_results))",
        "natural": "Under the condition that it is not the case that if study results have methodological flaws then they need replication, then they require peer review."
      },
      "(¬(A30 → A31) → ¬A32)": {
        "formal": "(¬(A30 → A31) → ¬A32)",
        "prover9": "(-(A30 -> A31) -> -A32)",
        "prover9_expression": "(-(has_methodological_flaws(study_results) -> needs_replication(study_results)) -> -requires_peer_review(study_results))",
        "natural": "If it is not the case that if study results have methodological flaws then they need replication, then they do not require peer review."
      },
      "(¬(A4 → ¬A5) → A6)": {
        "formal": "(¬(A4 → ¬A5) → A6)",
        "prover9": "(-(A4 -> -A5) -> A6)",
        "prover9_expression": "(-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> requires_monitoring(device_w))",
        "natural": "Provided that it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W requires monitoring."
      },
      "(¬(A4 → ¬A5) → ¬A6)": {
        "formal": "(¬(A4 → ¬A5) → ¬A6)",
        "prover9": "(-(A4 -> -A5) -> -A6)",
        "prover9_expression": "(-(approved_by(fda_agency) -> -causes_side_effects(substance_x)) -> -requires_monitoring(device_w))",
        "natural": "Whenever it is not the case that if it was approved by the FDA agency then substance X does not cause side effects, then device W does not require monitoring."
      },
      "(¬(¬(A15 → A13) → ¬A17) → A18)": {
        "formal": "(¬(¬(A15 → A13) → ¬A17) → A18)",
        "prover9": "(-(-(A15 -> A13) -> -A17) -> A18)",
        "prover9_expression": "(-(-(completes_phase_ii(substance_x) -> passes_safety_test(substance_x)) -> -receives_funding(project_p)) -> generates_revenue(substance_x))",
        "natural": "If it is not the case that if it is not the case that if substance X completes phase II then it passes safety test then project P does not receive funding, then substance X generates revenue."
      },
      "(¬(¬A1 → A2) → A3)": {
        "formal": "(¬(¬A1 → A2) → A3)",
        "prover9": "(-(-A1 -> A2) -> A3)",
        "prover9_expression": "(-(-researched(substance_x) -> published_on(platform_y)) -> tested_on(animal_model_z))",
        "natural": "Provided that it is not the case that if substance X was not researched then it was published on platform Y, then it was tested on animal model Z."
      },
      "(¬(¬A1 → A2) → ¬A3)": {
        "formal": "(¬(¬A1 → A2) → ¬A3)",
        "prover9": "(-(-A1 -> A2) -> -A3)",
        "prover9_expression": "(-(-researched(substance_x) -> published_on(platform_y)) -> -tested_on(animal_model_z))",
        "natural": "Under the condition that it is not the case that if substance X was not researched then it was published on platform Y, then it was not tested on animal model Z."
      },
      "(¬A1 → A2)": {
        "formal": "(¬A1 → A2)",
        "prover9": "(-A1 -> A2)",
        "prover9_expression": "(-researched(substance_x) -> published_on(platform_y))",
        "natural": "If substance X was not researched, then it was published on platform Y."
      },
      "(¬G → A8)": {
        "formal": "(¬G → A8)",
        "prover9": "(-G -> A8)",
        "prover9_expression": "(-beneficial_to_patients(substance_x) -> exhibits_toxicity(substance_x))",
        "natural": "Provided that it is not the case that substance X is beneficial to patients, then it exhibits toxicity."
      },
      "(¬G → ¬A8)": {
        "formal": "(¬G → ¬A8)",
        "prover9": "(-G -> -A8)",
        "prover9_expression": "(-beneficial_to_patients(substance_x) -> -exhibits_toxicity(substance_x))",
        "natural": "If it is not the case that substance X is beneficial to patients, then it does not exhibit toxicity."
      },
      "A1": {
        "formal": "A1",
        "prover9": "A1",
        "prover9_expression": "researched(substance_x)",
        "natural": "Substance X has been researched."
      },
      "A24": {
        "formal": "A24",
        "prover9": "A24",
        "prover9_expression": "improves_patient_outcomes(substance_x)",
        "natural": "Substance X improves patient outcomes."
      },
      "A7": {
        "formal": "A7",
        "prover9": "A7",
        "prover9_expression": "treats(disease_d)",
        "natural": "It treats disease D."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "beneficial_to_patients(substance_x)",
        "natural": "Substance X is beneficial to patients."
      },
      "¬A10": {
        "formal": "¬A10",
        "prover9": "-A10",
        "prover9_expression": "-fails_clinical_trial(substance_x)",
        "natural": "It is not the case that substance X fails clinical trial."
      },
      "¬A18": {
        "formal": "¬A18",
        "prover9": "-A18",
        "prover9_expression": "-generates_revenue(substance_x)",
        "natural": "It is not the case that substance X generates revenue."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-attracts_investment(project_p)",
        "natural": "It is not the case that project P attracts investment."
      },
      "¬A2": {
        "formal": "¬A2",
        "prover9": "-A2",
        "prover9_expression": "-published_on(platform_y)",
        "natural": "It is not the case that the research was published on platform Y."
      },
      "¬A23": {
        "formal": "¬A23",
        "prover9": "-A23",
        "prover9_expression": "-achieves_commercial_success(substance_x)",
        "natural": "It is not the case that substance X achieves commercial success."
      },
      "¬A27": {
        "formal": "¬A27",
        "prover9": "-A27",
        "prover9_expression": "-creates_confusion(study_results)",
        "natural": "It is not the case that study results create confusion."
      },
      "¬A4": {
        "formal": "¬A4",
        "prover9": "-A4",
        "prover9_expression": "-approved_by(fda_agency)",
        "natural": "It is not the case that it was approved by the FDA agency."
      },
      "¬A9": {
        "formal": "¬A9",
        "prover9": "-A9",
        "prover9_expression": "-shows_efficacy(substance_x)",
        "natural": "It is not the case that substance X shows efficacy."
      }
    }
  }
}